Expanded eligibility guidelines and the introduction of a powerful new drug may signal a new era for patients struggling to control their cholesterol. But cost, coverage, and, yes, side effects loom large.
A government pilot project will now allow a wide swath of Medicare beneficiaries to access popular weight-loss drugs at a bargain rate. But the risks, some experts argue, far outweigh the potential benefits.
If there’s a solution to age-related frailty, the latest research suggests it may lie in building — and maintaining — a healthy microbial mix in our aging guts. Or maybe not.